Your browser doesn't support javascript.
loading
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
Bogacheva, Mariia S; Kuivanen, Suvi; Potdar, Swapnil; Hassinen, Antti; Huuskonen, Sini; Pöhner, Ina; Luck, Tamara J; Turunen, Laura; Feodoroff, Michaela; Szirovicza, Leonora; Savijoki, Kirsi; Saarela, Jani; Tammela, Päivi; Paavolainen, Lassi; Poso, Antti; Varjosalo, Markku; Kallioniemi, Olli; Pietiäinen, Vilja; Vapalahti, Olli.
Afiliação
  • Bogacheva MS; Department of Virology, Medicum, University of Helsinki, Helsinki, Finland; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland. Electronic address: mariia.bogacheva@helsinki.fi.
  • Kuivanen S; Department of Virology, Medicum, University of Helsinki, Helsinki, Finland.
  • Potdar S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Hassinen A; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Huuskonen S; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Pöhner I; Faculty of Health Sciences, School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Luck TJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Turunen L; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Feodoroff M; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland; Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Szirovicza L; Department of Virology, Medicum, University of Helsinki, Helsinki, Finland.
  • Savijoki K; Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
  • Saarela J; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Tammela P; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Paavolainen L; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Poso A; Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; Department of Internal Medicine VIII, University Hospital Tubingen, Tubingen, Germany.
  • Varjosalo M; Institute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Finland.
  • Kallioniemi O; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland; Science for Life Laboratory (SciLifeLab), Department of Oncology and Pathology, Karolinska Institutet, Solna, Sweden.
  • Pietiäinen V; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland.
  • Vapalahti O; Department of Virology, Medicum, University of Helsinki, Helsinki, Finland; Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland; HUS Diagnostic Center, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital,
Antiviral Res ; 223: 105813, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38272320
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article